Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04206332
What this trial is testing

Trial to Evaluate CIS43LS in Healthy Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 71
Early research (Phase 1)Study completedNCT02253914
What this trial is testing

Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 100
Early research (Phase 1)Active Not RecruitingNCT07342114
What this trial is testing

A Clinical Study to Evaluate the Effects of RO7875913 in Healthy Participants and of RO7875913 With Cevostamab in Participnats With With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Healthy VolunteersRelapsed Multiple MyelomaRefractory Multiple Myeloma
Genentech, Inc. 240
Early research (Phase 1)Study completedNCT01301716
What this trial is testing

The Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 75
Early research (Phase 1)Study completedNCT01653444
What this trial is testing

Evaluate the Safety and Exploratory Efficacy of GC1119

Who this might be right for
Fabry Disease
Green Cross Corporation 8
Testing effectiveness (Phase 2)Study completedNCT02729571
What this trial is testing

Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults

Who this might be right for
Tuberculosis
Biofabri, S.L 54
Not applicableStudy completedNCT00020527
What this trial is testing

Caspofungin Acetate in Treating Children With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionKidney Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00460941
What this trial is testing

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 133
Early research (Phase 1)Study completedNCT01095302
What this trial is testing

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors

Who this might be right for
Neoplasms, Malignant
Sanofi 11
Early research (Phase 1)WithdrawnNCT06483802
What this trial is testing

ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia

Who this might be right for
Friedreich AtaxiaCardiomyopathy
Astellas Gene Therapies
Early research (Phase 1)Study completedNCT05019729
What this trial is testing

Trial to Evaluate L9LS in Healthy Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 32
Testing effectiveness (Phase 2)Looking for participantsNCT07179575
What this trial is testing

Study of LW231 in Participants With Chronic Hepatitis B

Who this might be right for
Chronic HBV Infection
Shanghai Longwood Biopharmaceuticals Co., Ltd. 270
Early research (Phase 1)Study completedNCT01015911
What this trial is testing

Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellLymphoma, Non-Hodgkin
Seagen Inc. 58
Large-scale testing (Phase 3)Study completedNCT00435045
What this trial is testing

Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia

Who this might be right for
Hypertriglyceridemia
GlaxoSmithKline 245
Testing effectiveness (Phase 2)WithdrawnNCT04260009
What this trial is testing

Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors

Who this might be right for
Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell LymphomaInflammatory Myofibroblastic TumorsSolid Tumors
Takeda
Testing effectiveness (Phase 2)Active Not RecruitingNCT06280209
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
BioMarin Pharmaceutical 18
Early research (Phase 1)Ended earlyNCT02045095
What this trial is testing

A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Millennium Pharmaceuticals, Inc. 29
Early research (Phase 1)UnknownNCT04801095
What this trial is testing

A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorColorectal Cancer+4 more
Wellmarker Bio 100
Early research (Phase 1)Looking for participantsNCT06612970
What this trial is testing

Evaluate Single-dose of HB0056 in Healthy Adult Participants

Who this might be right for
Healthy
Shanghai Huaota Biopharmaceutical Co., Ltd. 46
Early research (Phase 1)Ended earlyNCT02289495
What this trial is testing

A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 24
Next Page